Health ❯ Healthcare ❯ Chronic Diseases
Management Strategies Treatment Options Cardiovascular Risk Medication Effects Obesity Management and Treatment Weight Management Metabolic Disorders Cardiometabolic Health Management Treatment Effects Blood Sugar Regulation Insulin Sensitivity Cardiovascular Disease Insulin Therapy Statin Therapy Effects Insulin Regulation Metabolic Care Insulin Treatments Impact on Youth Insulin Response Cardiovascular Health Medication Comparison Obesity and Diabetes Connection Diabesity Epidemic Prevention and Management Metabolic Syndrome Dementia Risk Obesity Management Associated Conditions GLP-1 Receptor Agonists Tobacco Use Disorder SGLT-2 Inhibitors
Additional analyses followed by regulatory review will determine whether the amylin-plus-GLP-1 approach becomes a new treatment option for people with type 2 diabetes.
